A novel 3-(4,5-diphenyl-1,3-oxazol-2-yl)propanal oxime compound is a potent Transient Receptor Potential Ankyrin 1 and Vanilloid 1 (TRPA1 and V1) receptor antagonistMaja Payrits, Éva Szőke, Péter Mátyus et al.|Neuroscience|2016Cited by 31